Page last updated: 2024-10-30

losartan and Hematoma

losartan has been researched along with Hematoma in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Hematoma: A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.

Research Excerpts

ExcerptRelevanceReference
"Spontaneous rectus sheath haematomas and cough secondary to losartan are individually rare conditions."7.83Rare case of losartan-induced cough complicated by rectus sheath haematoma: in a patient on rivaroxaban therapy. ( Ahmed, S; Sweigart, J; Talari, G; Talari, P, 2016)
"Spontaneous rectus sheath haematomas and cough secondary to losartan are individually rare conditions."3.83Rare case of losartan-induced cough complicated by rectus sheath haematoma: in a patient on rivaroxaban therapy. ( Ahmed, S; Sweigart, J; Talari, G; Talari, P, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Talari, G1
Talari, P1
Sweigart, J1
Ahmed, S1

Other Studies

1 other study available for losartan and Hematoma

ArticleYear
Rare case of losartan-induced cough complicated by rectus sheath haematoma: in a patient on rivaroxaban therapy.
    BMJ case reports, 2016, Dec-23, Volume: 2016

    Topics: Aged; Antihypertensive Agents; Cough; Diagnosis, Differential; Factor Xa Inhibitors; Hematoma; Human

2016